HIMS

SEC source: 0000899243-21-014246 · doc4.xml · derivative · entry 6

Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 352

Underlying: Class A Common Stock · 352 shares

Expires not disclosed

F3 · derivative.exercise_price: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer.

F3 · derivative.exercise_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer.

F3 · derivative.expiration_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer.

SEC source: 0000899243-21-014246 · doc4.xml · derivative · entry 5

Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,724

Underlying: Class A Common Stock · 17,724 shares

Expires not disclosed

F3 · derivative.exercise_price: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer.

F3 · derivative.exercise_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer.

F3 · derivative.expiration_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer.

SEC source: 0000899243-21-014246 · doc4.xml · derivative · entry 4

Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 220

Underlying: Class A Common Stock · 220 shares

Expires not disclosed

F2 · derivative.exercise_price: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years on each Company Quarterly Vesting Date, subject to the Reporting Person's continuous service with the issuer.

F2 · derivative.exercise_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years on each Company Quarterly Vesting Date, subject to the Reporting Person's continuous service with the issuer.

F2 · derivative.expiration_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years on each Company Quarterly Vesting Date, subject to the Reporting Person's continuous service with the issuer.

SEC source: 0000899243-21-014246 · doc4.xml · derivative · entry 3

Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,077

Underlying: Class A Common Stock · 11,077 shares

Expires not disclosed

F2 · derivative.exercise_price: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years on each Company Quarterly Vesting Date, subject to the Reporting Person's continuous service with the issuer.

F2 · derivative.exercise_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years on each Company Quarterly Vesting Date, subject to the Reporting Person's continuous service with the issuer.

F2 · derivative.expiration_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years on each Company Quarterly Vesting Date, subject to the Reporting Person's continuous service with the issuer.

SEC source: 0000899243-21-014246 · doc4.xml · derivative · entry 2

Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132

Underlying: Class A Common Stock · 132 shares

Expires not disclosed

F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of September 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer.

F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of September 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer.

F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of September 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer.

SEC source: 0000899243-21-014246 · doc4.xml · derivative · entry 1

Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,646

Underlying: Class A Common Stock · 6,646 shares

Expires not disclosed

F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of September 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer.

F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of September 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer.

F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of September 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer.

SEC source: 0000899243-21-003122 · doc4.xml · derivative · entry 9

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,983

Underlying: Class A Common Stock · 12,983 shares

Expires not disclosed

F11 · derivative.exercise_price: In connection with the Merger, the Reporting Person received additional New Hims RSUs representing a portion of the aggregate 16,000,000 shares of New Hims Class A Common Stock comprising the Earn Out shares (the "Earn Out RSUs").

F12 · derivative.exercise_date: The Earn Out RSUs were received in exchange for shares of Legacy Hims RSUs. Subject to the satisfaction of time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition specified in Footnote 10 above. Additionally, the Earn Out RSUs will vest upon the satisfaction of the Earn Out conditions. If the RSU Earn Out conditions are not met during the Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited.

F12 · derivative.expiration_date: The Earn Out RSUs were received in exchange for shares of Legacy Hims RSUs. Subject to the satisfaction of time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition specified in Footnote 10 above. Additionally, the Earn Out RSUs will vest upon the satisfaction of the Earn Out conditions. If the RSU Earn Out conditions are not met during the Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited.

SEC source: 0000899243-21-003122 · doc4.xml · derivative · entry 8

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,723

Underlying: Class A Common Stock · 132,723 shares

Expires not disclosed

F9 · derivative.exercise_price: In connection with the Merger, the Reporting Person received New Hims restricted stock units ("New Hims RSUs") in exchange for restricted stock units of Hims, Inc. ("Legacy Hims RSUs").

F10 · derivative.exercise_date: The New Hims RSUs were received in exchange for 293,000 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period in substantially equal quarterly installments beginning March 15, 2021, with 6.25% of the RSUs vesting on each of March 15, June 15, September 15 and December 15, subject to the individual's continuous service. The New Hims RSU is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable RSU Agreement). The New Hims RSU expires in December 2027.

F10 · derivative.expiration_date: The New Hims RSUs were received in exchange for 293,000 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period in substantially equal quarterly installments beginning March 15, 2021, with 6.25% of the RSUs vesting on each of March 15, June 15, September 15 and December 15, subject to the individual's continuous service. The New Hims RSU is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable RSU Agreement). The New Hims RSU expires in December 2027.

SEC source: 0000899243-21-003122 · doc4.xml · derivative · entry 7

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,899

Underlying: Class A Common Stock · 265,899 shares

Expires 2030-12-22

F8 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 587,000 shares of Class A Common Stock of Hims, Inc., with an exercise price of $4.26, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous service beginning December 16, 2020. The Stock Option is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable Stock Option Agreement).

SEC source: 0000899243-21-003122 · doc4.xml · derivative · entry 6

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 779,073

Underlying: Class A Common Stock · 779,073 shares

Expires 2030-05-12

F7 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 1,719,884 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous service beginning February 12, 2020. The Stock Option is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable Stock Option Agreement).

SEC source: 0000899243-21-003122 · doc4.xml · derivative · entry 5

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,245

Underlying: Class A Common Stock · 113,245 shares

Expires 2029-11-05

F6 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 250,000 shares of Class A Common Stock of Hims, Inc., with an exercise price of $0.79, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous service beginning October 1, 2019.

SEC source: 0000899243-21-003122 · doc4.xml · derivative · entry 4

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 925,664

Underlying: Class A Common Stock · 925,664 shares

Expires 2028-03-28

F5 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 2,043,499 shares of Class A Common Stock of Hims, Inc., with an exercise price of $0.18, in connection with the Merger. 1/4 of the shares subject to the Stock Option vest on the 12 month anniversary of the vesting commencement date and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the 12 month anniversary of the vesting commencement date, beginning February 6, 2018.

SEC source: 0000899243-21-003122 · doc4.xml · derivative · entry 3

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 161,059

Underlying: Class A Common Stock · 161,059 shares

Expires 2028-03-28

F4 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 355,555 shares of Class A Common Stock of Hims, Inc., with an exercise price of $0.18, in connection with the Merger. 1/4 of the shares subject to the Stock Option vest on the 12 month anniversary of the vesting commencement date and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the 12 month anniversary of the vesting commencement date, beginning February 6, 2018.

SEC source: 0000899243-21-003122 · doc4.xml · derivative · entry 2

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 556

Underlying: Class A Common Stock · 556 shares

Expires 2026-01-20

F3 · derivative.exercise_date: In connection with the Merger, the Reporting Person received warrants exercisable for shares of New Hims Class A Common Stock in partial exchange for shares of Class A Common Stock of Hims, Inc.

SEC source: 0000899243-21-003122 · doc4.xml · nonDerivative · entry 1

Baird Melissa · CIK 0001837815 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,458

F1 · price: In connection with the merger described in that certain Agreement and Plan of Merger, dated as of September 30, 2020 (the "Merger"), by and among Oaktree Acquisition Corp., now known as Hims & Hers Health, Inc. ("New Hims"), RX Merger Sub Inc., and Hims, Inc., the Reporting Person received (i) 90,596 shares of Class A Common Stock of New Hims and (ii) 8,862 shares of restricted New Hims Class A Common Stock (the "Earn Out Shares") in exchange for 200,000 shares of Class A Common Stock of Hims, Inc. The Earn Out Shares vest in equal thirds if the trading price of New Hims Class A Common Stock is greater than or equal to $15, $17.50 and $20 for any 10 trading days within any 20-trading day period (the "Earn Out Conditions"). If the Earn Out Conditions are not met during the five years following closing (the "Earn Out Period"), then the unvested Earn Out Shares will be automatically forfeited.

F2 · price: (Continued from footnote 1)On the effective date of the Merger, the closing price of New Hims Class A Common Stock was $16.38 per share.

SEC source: 0000899243-21-003052 · doc4.xml · derivative · entry 3

Oaktree Acquisition Holdings, L.P. · CIK 0001773790 · 10% owner

Partners Ltd · CIK 0001540229 · 10% owner

Oaktree Acquisition Holdings GP Ltd. · CIK 0001773788 · 10% owner

OAKTREE CAPITAL MANAGEMENT LP · CIK 0000949509 · 10% owner

Oaktree Capital Management GP, LLC · CIK 0001831013 · 10% owner

Atlas OCM Holdings, LLC · CIK 0001790787 · 10% owner

Oaktree Capital Group Holdings GP, LLC · CIK 0001403525 · 10% owner

BROOKFIELD ASSET MANAGEMENT INC. · CIK 0001001085 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,012,500

Underlying: Class A Common Stock · 3,012,500 shares

Expires not disclosed

F6 · derivative.exercise_price: In connection with the Domestication, 1,004,167 of the private placement warrants of the Company ("OAC Private Placement Warrants) held by Holdings, which previously entitled Holdings to purchase one OAC Class A Ordinary Share at a price of $11.50 per whole share at any time commencing on the later of one year from the closing of the Company's initial public offering or thirty (30) days after the completion of an initial business combination of the Company, were forfeited and surrendered for no consideration and the remaining 3,012,500 OAC Private Placement Warrants converted into warrants of New Hims (each a "New Hims Warrant") simultaneously with the closing of the Business Combination, with each whole New Hims Warrant entitling the holder thereof to the right to purchase one share of New Hims Class A Common Stock.

F6 · kind: In connection with the Domestication, 1,004,167 of the private placement warrants of the Company ("OAC Private Placement Warrants) held by Holdings, which previously entitled Holdings to purchase one OAC Class A Ordinary Share at a price of $11.50 per whole share at any time commencing on the later of one year from the closing of the Company's initial public offering or thirty (30) days after the completion of an initial business combination of the Company, were forfeited and surrendered for no consideration and the remaining 3,012,500 OAC Private Placement Warrants converted into warrants of New Hims (each a "New Hims Warrant") simultaneously with the closing of the Business Combination, with each whole New Hims Warrant entitling the holder thereof to the right to purchase one share of New Hims Class A Common Stock.

F6 · shares: In connection with the Domestication, 1,004,167 of the private placement warrants of the Company ("OAC Private Placement Warrants) held by Holdings, which previously entitled Holdings to purchase one OAC Class A Ordinary Share at a price of $11.50 per whole share at any time commencing on the later of one year from the closing of the Company's initial public offering or thirty (30) days after the completion of an initial business combination of the Company, were forfeited and surrendered for no consideration and the remaining 3,012,500 OAC Private Placement Warrants converted into warrants of New Hims (each a "New Hims Warrant") simultaneously with the closing of the Business Combination, with each whole New Hims Warrant entitling the holder thereof to the right to purchase one share of New Hims Class A Common Stock.

F6 · price: In connection with the Domestication, 1,004,167 of the private placement warrants of the Company ("OAC Private Placement Warrants) held by Holdings, which previously entitled Holdings to purchase one OAC Class A Ordinary Share at a price of $11.50 per whole share at any time commencing on the later of one year from the closing of the Company's initial public offering or thirty (30) days after the completion of an initial business combination of the Company, were forfeited and surrendered for no consideration and the remaining 3,012,500 OAC Private Placement Warrants converted into warrants of New Hims (each a "New Hims Warrant") simultaneously with the closing of the Business Combination, with each whole New Hims Warrant entitling the holder thereof to the right to purchase one share of New Hims Class A Common Stock.

F6 · derivative.exercise_date: In connection with the Domestication, 1,004,167 of the private placement warrants of the Company ("OAC Private Placement Warrants) held by Holdings, which previously entitled Holdings to purchase one OAC Class A Ordinary Share at a price of $11.50 per whole share at any time commencing on the later of one year from the closing of the Company's initial public offering or thirty (30) days after the completion of an initial business combination of the Company, were forfeited and surrendered for no consideration and the remaining 3,012,500 OAC Private Placement Warrants converted into warrants of New Hims (each a "New Hims Warrant") simultaneously with the closing of the Business Combination, with each whole New Hims Warrant entitling the holder thereof to the right to purchase one share of New Hims Class A Common Stock.

F6 · derivative.expiration_date: In connection with the Domestication, 1,004,167 of the private placement warrants of the Company ("OAC Private Placement Warrants) held by Holdings, which previously entitled Holdings to purchase one OAC Class A Ordinary Share at a price of $11.50 per whole share at any time commencing on the later of one year from the closing of the Company's initial public offering or thirty (30) days after the completion of an initial business combination of the Company, were forfeited and surrendered for no consideration and the remaining 3,012,500 OAC Private Placement Warrants converted into warrants of New Hims (each a "New Hims Warrant") simultaneously with the closing of the Business Combination, with each whole New Hims Warrant entitling the holder thereof to the right to purchase one share of New Hims Class A Common Stock.

F6 · derivative.underlying_shares: In connection with the Domestication, 1,004,167 of the private placement warrants of the Company ("OAC Private Placement Warrants) held by Holdings, which previously entitled Holdings to purchase one OAC Class A Ordinary Share at a price of $11.50 per whole share at any time commencing on the later of one year from the closing of the Company's initial public offering or thirty (30) days after the completion of an initial business combination of the Company, were forfeited and surrendered for no consideration and the remaining 3,012,500 OAC Private Placement Warrants converted into warrants of New Hims (each a "New Hims Warrant") simultaneously with the closing of the Business Combination, with each whole New Hims Warrant entitling the holder thereof to the right to purchase one share of New Hims Class A Common Stock.

F6 · balance_after: In connection with the Domestication, 1,004,167 of the private placement warrants of the Company ("OAC Private Placement Warrants) held by Holdings, which previously entitled Holdings to purchase one OAC Class A Ordinary Share at a price of $11.50 per whole share at any time commencing on the later of one year from the closing of the Company's initial public offering or thirty (30) days after the completion of an initial business combination of the Company, were forfeited and surrendered for no consideration and the remaining 3,012,500 OAC Private Placement Warrants converted into warrants of New Hims (each a "New Hims Warrant") simultaneously with the closing of the Business Combination, with each whole New Hims Warrant entitling the holder thereof to the right to purchase one share of New Hims Class A Common Stock.

F1 · ownership.direct: This Form 4 is being filed by Oaktree Acquisition Holdings, L.P. ("Holdings"). The general partner of Holdings is Oaktree Acquisition Holdings GP Ltd. ("Holdings GP"). The director of Holdings GP is Oaktree Capital Management, L.P. ("Oaktree"). The general partner of Oaktree is Oaktree Capital Management GP, LLC ("Management GP"). The sole member of Management GP is Atlas OCM Holdings, LLC ("Atlas"). Oaktree Capital Group Holdings GP, LLC ("OCGH GP") is the indirect owner of the class B units of Atlas and has the ability to appoint and remove certain directors of Atlas and, as such, may indirectly control the decisions of Atlas regarding the vote and disposition of securities held by Holdings; therefore, OCGH GP may be deemed to have indirect beneficial ownership of the New Hims Class A Common Stock (as defined below) held by Holdings.

F2 · ownership.direct: (Continued from Footnote 1) Brookfield Asset Management, Inc. ("BAM"), in its capacity as the indirect owner of the class A units of each of OCG GP and Atlas, has the ability to appoint and remove certain directors of Atlas and, as such, may indirectly control the decisions of Atlas regarding the vote and disposition of securities held by Holdings; therefore BAM may be deemed to have indirect beneficial ownership of the Hims Class A Common Stock (as defined below) held by Holdings. Partners Limited ("Partners"), in its capacity as the sole owner of Class B Limited Voting Shares of BAM, has the ability to appoint and remove certain directors of BAM and, as such, may indirectly control the decisions of BAM regarding the vote and disposition of securities held by Holdings; therefore Partners may be deemed to have indirect beneficial ownership of the Hims Class A Common Stock held by Holdings.

F3 · ownership.direct: (Continued from Footnote 2) Each reporting person under this Form 4 disclaims beneficial ownership of the securities reported herein except to the extent of their respective pecuniary interest therein and the filing of this Form 4 shall not be construed as an admission that any such reporting person is the beneficial owner of any securities covered by this Form 4.

SEC source: 0000899243-21-003052 · doc4.xml · derivative · entry 2

Oaktree Acquisition Holdings, L.P. · CIK 0001773790 · 10% owner

Partners Ltd · CIK 0001540229 · 10% owner

Oaktree Acquisition Holdings GP Ltd. · CIK 0001773788 · 10% owner

OAKTREE CAPITAL MANAGEMENT LP · CIK 0000949509 · 10% owner

Oaktree Capital Management GP, LLC · CIK 0001831013 · 10% owner

Atlas OCM Holdings, LLC · CIK 0001790787 · 10% owner

Oaktree Capital Group Holdings GP, LLC · CIK 0001403525 · 10% owner

BROOKFIELD ASSET MANAGEMENT INC. · CIK 0001001085 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A ordinary shares · 5,031,250 shares

Expires not disclosed

F4 · derivative.exercise_price: In connection with the Agreement and Plan of Merger, dated September 30, 2020, by and among Oaktree Acquisition Corp. (the "Company"), Hims, Inc. ("Hims"), and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), the Company domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hims & Hers, Inc." ("New Hims"). In connection with the Domestication, 1,257,813 of Holdings' Class B ordinary shares, par value $0.0001, of the Company ("OAC Class B Ordinary Shares"), which were previously convertible into Class A ordinary shares, par value $0.0001, of the Company ("OAC Class A Ordinary Shares"), were forfeited and surrendered for no consideration and the remaining 3,773,437 OAC Class B Ordinary Shares held by Holdings converted to shares of Class A common stock, par value $0.0001, of New Hims ("New Hims Class A Common Stock") simultaneously with the closing of the Business Combination.

F4 · kind: In connection with the Agreement and Plan of Merger, dated September 30, 2020, by and among Oaktree Acquisition Corp. (the "Company"), Hims, Inc. ("Hims"), and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), the Company domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hims & Hers, Inc." ("New Hims"). In connection with the Domestication, 1,257,813 of Holdings' Class B ordinary shares, par value $0.0001, of the Company ("OAC Class B Ordinary Shares"), which were previously convertible into Class A ordinary shares, par value $0.0001, of the Company ("OAC Class A Ordinary Shares"), were forfeited and surrendered for no consideration and the remaining 3,773,437 OAC Class B Ordinary Shares held by Holdings converted to shares of Class A common stock, par value $0.0001, of New Hims ("New Hims Class A Common Stock") simultaneously with the closing of the Business Combination.

F5 · kind: (Continued from Footnote 4) After giving effect to this transaction, Holdings will own less than 10% of the outstanding common stock of New Hims.

F4 · shares: In connection with the Agreement and Plan of Merger, dated September 30, 2020, by and among Oaktree Acquisition Corp. (the "Company"), Hims, Inc. ("Hims"), and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), the Company domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hims & Hers, Inc." ("New Hims"). In connection with the Domestication, 1,257,813 of Holdings' Class B ordinary shares, par value $0.0001, of the Company ("OAC Class B Ordinary Shares"), which were previously convertible into Class A ordinary shares, par value $0.0001, of the Company ("OAC Class A Ordinary Shares"), were forfeited and surrendered for no consideration and the remaining 3,773,437 OAC Class B Ordinary Shares held by Holdings converted to shares of Class A common stock, par value $0.0001, of New Hims ("New Hims Class A Common Stock") simultaneously with the closing of the Business Combination.

F5 · shares: (Continued from Footnote 4) After giving effect to this transaction, Holdings will own less than 10% of the outstanding common stock of New Hims.

F4 · price: In connection with the Agreement and Plan of Merger, dated September 30, 2020, by and among Oaktree Acquisition Corp. (the "Company"), Hims, Inc. ("Hims"), and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), the Company domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hims & Hers, Inc." ("New Hims"). In connection with the Domestication, 1,257,813 of Holdings' Class B ordinary shares, par value $0.0001, of the Company ("OAC Class B Ordinary Shares"), which were previously convertible into Class A ordinary shares, par value $0.0001, of the Company ("OAC Class A Ordinary Shares"), were forfeited and surrendered for no consideration and the remaining 3,773,437 OAC Class B Ordinary Shares held by Holdings converted to shares of Class A common stock, par value $0.0001, of New Hims ("New Hims Class A Common Stock") simultaneously with the closing of the Business Combination.

F5 · price: (Continued from Footnote 4) After giving effect to this transaction, Holdings will own less than 10% of the outstanding common stock of New Hims.

F4 · derivative.exercise_date: In connection with the Agreement and Plan of Merger, dated September 30, 2020, by and among Oaktree Acquisition Corp. (the "Company"), Hims, Inc. ("Hims"), and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), the Company domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hims & Hers, Inc." ("New Hims"). In connection with the Domestication, 1,257,813 of Holdings' Class B ordinary shares, par value $0.0001, of the Company ("OAC Class B Ordinary Shares"), which were previously convertible into Class A ordinary shares, par value $0.0001, of the Company ("OAC Class A Ordinary Shares"), were forfeited and surrendered for no consideration and the remaining 3,773,437 OAC Class B Ordinary Shares held by Holdings converted to shares of Class A common stock, par value $0.0001, of New Hims ("New Hims Class A Common Stock") simultaneously with the closing of the Business Combination.

F5 · derivative.exercise_date: (Continued from Footnote 4) After giving effect to this transaction, Holdings will own less than 10% of the outstanding common stock of New Hims.

F4 · derivative.expiration_date: In connection with the Agreement and Plan of Merger, dated September 30, 2020, by and among Oaktree Acquisition Corp. (the "Company"), Hims, Inc. ("Hims"), and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), the Company domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hims & Hers, Inc." ("New Hims"). In connection with the Domestication, 1,257,813 of Holdings' Class B ordinary shares, par value $0.0001, of the Company ("OAC Class B Ordinary Shares"), which were previously convertible into Class A ordinary shares, par value $0.0001, of the Company ("OAC Class A Ordinary Shares"), were forfeited and surrendered for no consideration and the remaining 3,773,437 OAC Class B Ordinary Shares held by Holdings converted to shares of Class A common stock, par value $0.0001, of New Hims ("New Hims Class A Common Stock") simultaneously with the closing of the Business Combination.

F5 · derivative.expiration_date: (Continued from Footnote 4) After giving effect to this transaction, Holdings will own less than 10% of the outstanding common stock of New Hims.

F4 · derivative.underlying_shares: In connection with the Agreement and Plan of Merger, dated September 30, 2020, by and among Oaktree Acquisition Corp. (the "Company"), Hims, Inc. ("Hims"), and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), the Company domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hims & Hers, Inc." ("New Hims"). In connection with the Domestication, 1,257,813 of Holdings' Class B ordinary shares, par value $0.0001, of the Company ("OAC Class B Ordinary Shares"), which were previously convertible into Class A ordinary shares, par value $0.0001, of the Company ("OAC Class A Ordinary Shares"), were forfeited and surrendered for no consideration and the remaining 3,773,437 OAC Class B Ordinary Shares held by Holdings converted to shares of Class A common stock, par value $0.0001, of New Hims ("New Hims Class A Common Stock") simultaneously with the closing of the Business Combination.

F5 · derivative.underlying_shares: (Continued from Footnote 4) After giving effect to this transaction, Holdings will own less than 10% of the outstanding common stock of New Hims.

F4 · balance_after: In connection with the Agreement and Plan of Merger, dated September 30, 2020, by and among Oaktree Acquisition Corp. (the "Company"), Hims, Inc. ("Hims"), and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), the Company domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hims & Hers, Inc." ("New Hims"). In connection with the Domestication, 1,257,813 of Holdings' Class B ordinary shares, par value $0.0001, of the Company ("OAC Class B Ordinary Shares"), which were previously convertible into Class A ordinary shares, par value $0.0001, of the Company ("OAC Class A Ordinary Shares"), were forfeited and surrendered for no consideration and the remaining 3,773,437 OAC Class B Ordinary Shares held by Holdings converted to shares of Class A common stock, par value $0.0001, of New Hims ("New Hims Class A Common Stock") simultaneously with the closing of the Business Combination.

F5 · balance_after: (Continued from Footnote 4) After giving effect to this transaction, Holdings will own less than 10% of the outstanding common stock of New Hims.

F1 · ownership.direct: This Form 4 is being filed by Oaktree Acquisition Holdings, L.P. ("Holdings"). The general partner of Holdings is Oaktree Acquisition Holdings GP Ltd. ("Holdings GP"). The director of Holdings GP is Oaktree Capital Management, L.P. ("Oaktree"). The general partner of Oaktree is Oaktree Capital Management GP, LLC ("Management GP"). The sole member of Management GP is Atlas OCM Holdings, LLC ("Atlas"). Oaktree Capital Group Holdings GP, LLC ("OCGH GP") is the indirect owner of the class B units of Atlas and has the ability to appoint and remove certain directors of Atlas and, as such, may indirectly control the decisions of Atlas regarding the vote and disposition of securities held by Holdings; therefore, OCGH GP may be deemed to have indirect beneficial ownership of the New Hims Class A Common Stock (as defined below) held by Holdings.

F2 · ownership.direct: (Continued from Footnote 1) Brookfield Asset Management, Inc. ("BAM"), in its capacity as the indirect owner of the class A units of each of OCG GP and Atlas, has the ability to appoint and remove certain directors of Atlas and, as such, may indirectly control the decisions of Atlas regarding the vote and disposition of securities held by Holdings; therefore BAM may be deemed to have indirect beneficial ownership of the Hims Class A Common Stock (as defined below) held by Holdings. Partners Limited ("Partners"), in its capacity as the sole owner of Class B Limited Voting Shares of BAM, has the ability to appoint and remove certain directors of BAM and, as such, may indirectly control the decisions of BAM regarding the vote and disposition of securities held by Holdings; therefore Partners may be deemed to have indirect beneficial ownership of the Hims Class A Common Stock held by Holdings.

F3 · ownership.direct: (Continued from Footnote 2) Each reporting person under this Form 4 disclaims beneficial ownership of the securities reported herein except to the extent of their respective pecuniary interest therein and the filing of this Form 4 shall not be construed as an admission that any such reporting person is the beneficial owner of any securities covered by this Form 4.

SEC source: 0000899243-21-003052 · doc4.xml · nonDerivative · entry 1

Oaktree Acquisition Holdings, L.P. · CIK 0001773790 · 10% owner

Partners Ltd · CIK 0001540229 · 10% owner

Oaktree Acquisition Holdings GP Ltd. · CIK 0001773788 · 10% owner

OAKTREE CAPITAL MANAGEMENT LP · CIK 0000949509 · 10% owner

Oaktree Capital Management GP, LLC · CIK 0001831013 · 10% owner

Atlas OCM Holdings, LLC · CIK 0001790787 · 10% owner

Oaktree Capital Group Holdings GP, LLC · CIK 0001403525 · 10% owner

BROOKFIELD ASSET MANAGEMENT INC. · CIK 0001001085 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,773,437

F4 · kind: In connection with the Agreement and Plan of Merger, dated September 30, 2020, by and among Oaktree Acquisition Corp. (the "Company"), Hims, Inc. ("Hims"), and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), the Company domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hims & Hers, Inc." ("New Hims"). In connection with the Domestication, 1,257,813 of Holdings' Class B ordinary shares, par value $0.0001, of the Company ("OAC Class B Ordinary Shares"), which were previously convertible into Class A ordinary shares, par value $0.0001, of the Company ("OAC Class A Ordinary Shares"), were forfeited and surrendered for no consideration and the remaining 3,773,437 OAC Class B Ordinary Shares held by Holdings converted to shares of Class A common stock, par value $0.0001, of New Hims ("New Hims Class A Common Stock") simultaneously with the closing of the Business Combination.

F5 · kind: (Continued from Footnote 4) After giving effect to this transaction, Holdings will own less than 10% of the outstanding common stock of New Hims.

F4 · shares: In connection with the Agreement and Plan of Merger, dated September 30, 2020, by and among Oaktree Acquisition Corp. (the "Company"), Hims, Inc. ("Hims"), and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), the Company domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hims & Hers, Inc." ("New Hims"). In connection with the Domestication, 1,257,813 of Holdings' Class B ordinary shares, par value $0.0001, of the Company ("OAC Class B Ordinary Shares"), which were previously convertible into Class A ordinary shares, par value $0.0001, of the Company ("OAC Class A Ordinary Shares"), were forfeited and surrendered for no consideration and the remaining 3,773,437 OAC Class B Ordinary Shares held by Holdings converted to shares of Class A common stock, par value $0.0001, of New Hims ("New Hims Class A Common Stock") simultaneously with the closing of the Business Combination.

F5 · shares: (Continued from Footnote 4) After giving effect to this transaction, Holdings will own less than 10% of the outstanding common stock of New Hims.

F4 · price: In connection with the Agreement and Plan of Merger, dated September 30, 2020, by and among Oaktree Acquisition Corp. (the "Company"), Hims, Inc. ("Hims"), and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), the Company domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hims & Hers, Inc." ("New Hims"). In connection with the Domestication, 1,257,813 of Holdings' Class B ordinary shares, par value $0.0001, of the Company ("OAC Class B Ordinary Shares"), which were previously convertible into Class A ordinary shares, par value $0.0001, of the Company ("OAC Class A Ordinary Shares"), were forfeited and surrendered for no consideration and the remaining 3,773,437 OAC Class B Ordinary Shares held by Holdings converted to shares of Class A common stock, par value $0.0001, of New Hims ("New Hims Class A Common Stock") simultaneously with the closing of the Business Combination.

F5 · price: (Continued from Footnote 4) After giving effect to this transaction, Holdings will own less than 10% of the outstanding common stock of New Hims.

F4 · acquired: In connection with the Agreement and Plan of Merger, dated September 30, 2020, by and among Oaktree Acquisition Corp. (the "Company"), Hims, Inc. ("Hims"), and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), the Company domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hims & Hers, Inc." ("New Hims"). In connection with the Domestication, 1,257,813 of Holdings' Class B ordinary shares, par value $0.0001, of the Company ("OAC Class B Ordinary Shares"), which were previously convertible into Class A ordinary shares, par value $0.0001, of the Company ("OAC Class A Ordinary Shares"), were forfeited and surrendered for no consideration and the remaining 3,773,437 OAC Class B Ordinary Shares held by Holdings converted to shares of Class A common stock, par value $0.0001, of New Hims ("New Hims Class A Common Stock") simultaneously with the closing of the Business Combination.

F5 · acquired: (Continued from Footnote 4) After giving effect to this transaction, Holdings will own less than 10% of the outstanding common stock of New Hims.

F4 · balance_after: In connection with the Agreement and Plan of Merger, dated September 30, 2020, by and among Oaktree Acquisition Corp. (the "Company"), Hims, Inc. ("Hims"), and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), the Company domesticated as a Delaware corporation (the "Domestication") and changed its name to "Hims & Hers, Inc." ("New Hims"). In connection with the Domestication, 1,257,813 of Holdings' Class B ordinary shares, par value $0.0001, of the Company ("OAC Class B Ordinary Shares"), which were previously convertible into Class A ordinary shares, par value $0.0001, of the Company ("OAC Class A Ordinary Shares"), were forfeited and surrendered for no consideration and the remaining 3,773,437 OAC Class B Ordinary Shares held by Holdings converted to shares of Class A common stock, par value $0.0001, of New Hims ("New Hims Class A Common Stock") simultaneously with the closing of the Business Combination.

F5 · balance_after: (Continued from Footnote 4) After giving effect to this transaction, Holdings will own less than 10% of the outstanding common stock of New Hims.

F1 · ownership.direct: This Form 4 is being filed by Oaktree Acquisition Holdings, L.P. ("Holdings"). The general partner of Holdings is Oaktree Acquisition Holdings GP Ltd. ("Holdings GP"). The director of Holdings GP is Oaktree Capital Management, L.P. ("Oaktree"). The general partner of Oaktree is Oaktree Capital Management GP, LLC ("Management GP"). The sole member of Management GP is Atlas OCM Holdings, LLC ("Atlas"). Oaktree Capital Group Holdings GP, LLC ("OCGH GP") is the indirect owner of the class B units of Atlas and has the ability to appoint and remove certain directors of Atlas and, as such, may indirectly control the decisions of Atlas regarding the vote and disposition of securities held by Holdings; therefore, OCGH GP may be deemed to have indirect beneficial ownership of the New Hims Class A Common Stock (as defined below) held by Holdings.

F2 · ownership.direct: (Continued from Footnote 1) Brookfield Asset Management, Inc. ("BAM"), in its capacity as the indirect owner of the class A units of each of OCG GP and Atlas, has the ability to appoint and remove certain directors of Atlas and, as such, may indirectly control the decisions of Atlas regarding the vote and disposition of securities held by Holdings; therefore BAM may be deemed to have indirect beneficial ownership of the Hims Class A Common Stock (as defined below) held by Holdings. Partners Limited ("Partners"), in its capacity as the sole owner of Class B Limited Voting Shares of BAM, has the ability to appoint and remove certain directors of BAM and, as such, may indirectly control the decisions of BAM regarding the vote and disposition of securities held by Holdings; therefore Partners may be deemed to have indirect beneficial ownership of the Hims Class A Common Stock held by Holdings.

F3 · ownership.direct: (Continued from Footnote 2) Each reporting person under this Form 4 disclaims beneficial ownership of the securities reported herein except to the extent of their respective pecuniary interest therein and the filing of this Form 4 shall not be construed as an admission that any such reporting person is the beneficial owner of any securities covered by this Form 4.

SEC source: 0000899243-21-003093 · doc4.xml · derivative · entry 2

WELLS DAVID B · CIK 0001507645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,295

Underlying: Class A Common Stock · 14,295 shares

Expires not disclosed

F3 · derivative.exercise_price: In connection with the Merger, the Reporting Person received additional New Hims RSUs representing a portion of the aggregate 16,000,000 shares of New Hims Class A Common Stock comprising the Earn Out shares (the "Earn Out RSUs").

F4 · derivative.exercise_date: The Earn Out RSUs were received in exchange for shares of Legacy Hims RSUs. Subject to the satisfaction of time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition specified in Footnote 2 above. Additionally, the Earn Out RSUs will vest in equal thirds if the trading price of New Hims Class A Common Stock is greater than or equal to $15, $17.50 and $20 for any 10 trading days within any 20-trading day period (the "Earn Out Conditions"). If the RSU Earn Out Conditions are not met during the Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited.

F4 · derivative.expiration_date: The Earn Out RSUs were received in exchange for shares of Legacy Hims RSUs. Subject to the satisfaction of time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition specified in Footnote 2 above. Additionally, the Earn Out RSUs will vest in equal thirds if the trading price of New Hims Class A Common Stock is greater than or equal to $15, $17.50 and $20 for any 10 trading days within any 20-trading day period (the "Earn Out Conditions"). If the RSU Earn Out Conditions are not met during the Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited.

SEC source: 0000899243-21-003093 · doc4.xml · derivative · entry 1

WELLS DAVID B · CIK 0001507645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,137

Underlying: Class A Common Stock · 146,137 shares

Expires not disclosed

F1 · derivative.exercise_price: In connection with the merger described in that certain Agreement and Plan of Merger, dated as of September 30, 2020 (the "Merger"), by and among Oaktree Acquisition Corp., now known as Hims & Hers Health, Inc. ("New Hims"), RX Merger Sub Inc., and Hims, Inc., the Reporting Person received New Hims restricted stock units ("New Hims RSUs") in exchange for restricted stock units of Hims, Inc. ("Legacy Hims RSUs").

F2 · derivative.exercise_date: The New Hims RSUs were received in exchange for 322,613 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period commencing in December 2020, with 25% vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or following the one-year anniversary of the vesting commencement date and the remaining 75% of the New Hims RSUs vesting in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter, subject to the individual's continuous service with Him News. The New Hims RSUs expire is November 2027.

F2 · derivative.expiration_date: The New Hims RSUs were received in exchange for 322,613 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period commencing in December 2020, with 25% vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or following the one-year anniversary of the vesting commencement date and the remaining 75% of the New Hims RSUs vesting in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter, subject to the individual's continuous service with Him News. The New Hims RSUs expire is November 2027.

SEC source: 0000899243-21-003103 · doc4.xml · derivative · entry 8

Maltz Jules A. · CIK 0001553254 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,485

Underlying: Class A Common Stock · 3,485 shares

Expires not disclosed

F8 · derivative.exercise_price: In connection with the Merger, the Reporting Person received additional New Hims RSUs representing a portion of the aggregate 16,000,000 shares of New Hims Class A Common Stock comprising the Earn Out shares (the "Earn Out RSUs").

F9 · derivative.exercise_date: The Earn Out RSUs were received in exchange for Legacy Hims RSUs. Subject to the satisfaction of a time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition as specified in Footnote 7 above. Additionally, the Earn Out RSUs will vest upon the satisfaction of the Earn Out conditions. If the RSU Earn Out Conditions are not met during the RSU Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited.

F9 · derivative.expiration_date: The Earn Out RSUs were received in exchange for Legacy Hims RSUs. Subject to the satisfaction of a time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition as specified in Footnote 7 above. Additionally, the Earn Out RSUs will vest upon the satisfaction of the Earn Out conditions. If the RSU Earn Out Conditions are not met during the RSU Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited.

SEC source: 0000899243-21-003103 · doc4.xml · derivative · entry 7

Maltz Jules A. · CIK 0001553254 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,627

Underlying: Class A Common Stock · 35,627 shares

Expires not disclosed

F6 · derivative.exercise_price: In connection with the Merger, the Reporting Person received New Hims restricted stock units ("New Hims RSUs") in exchange for restricted stock units of Hims, Inc. ("Legacy Hims RSUs").

F7 · derivative.exercise_date: The New Hims RSUs were received in exchange for 78,651 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period beginning March 2021, with 25% of the New Hims RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of the vesting commencement date and the remaining 75% of the New Hims RSUs vesting in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter, subject to the individual's continuous service with New Hims. The New Hims RSU expires in January 2028.

F7 · derivative.expiration_date: The New Hims RSUs were received in exchange for 78,651 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period beginning March 2021, with 25% of the New Hims RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of the vesting commencement date and the remaining 75% of the New Hims RSUs vesting in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter, subject to the individual's continuous service with New Hims. The New Hims RSU expires in January 2028.

SEC source: 0000899243-21-003103 · doc4.xml · derivative · entry 6

Maltz Jules A. · CIK 0001553254 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Institutional Venture Partners XVI, L.P.

Disclosed balance after: 56,961

Underlying: Class A Common Stock · 56,961 shares

Expires 2026-01-20

F5 · derivative.exercise_date: In connection with the Merger, the Reporting Person received warrants exercisable for shares of New Hims Class A Common Stock in exchange for Class A Common Stock of Hims, Inc.

F10 · ownership.nature: Mr. Maltz is a managing director of Institutional Venture Management XV LLC, which is the general partner of Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV Executive Fund") and Institutional Venture Partners XV, L.P. ("IVP XV"), and Institutional Venture Management XVI LLC, which is the general partner of Institutional Venture Partners XVI, L.P. ("IVP XVI"). Mr. Maltz may be deemed a beneficial owner of the securities held by IVP XV Executive Fund, IVP XV and IVP XVI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.

SEC source: 0000899243-21-003103 · doc4.xml · derivative · entry 5

Maltz Jules A. · CIK 0001553254 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Institutional Venture Partners XV, L.P.

Disclosed balance after: 56,659

Underlying: Class A Common Stock · 56,659 shares

Expires 2026-01-20

F5 · derivative.exercise_date: In connection with the Merger, the Reporting Person received warrants exercisable for shares of New Hims Class A Common Stock in exchange for Class A Common Stock of Hims, Inc.

F10 · ownership.nature: Mr. Maltz is a managing director of Institutional Venture Management XV LLC, which is the general partner of Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV Executive Fund") and Institutional Venture Partners XV, L.P. ("IVP XV"), and Institutional Venture Management XVI LLC, which is the general partner of Institutional Venture Partners XVI, L.P. ("IVP XVI"). Mr. Maltz may be deemed a beneficial owner of the securities held by IVP XV Executive Fund, IVP XV and IVP XVI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.

SEC source: 0000899243-21-003103 · doc4.xml · derivative · entry 4

Maltz Jules A. · CIK 0001553254 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Institutional Venture Partners XV Executive Fund, L.P.

Disclosed balance after: 297

Underlying: Class A Common Stock · 297 shares

Expires 2026-01-20

F5 · derivative.exercise_date: In connection with the Merger, the Reporting Person received warrants exercisable for shares of New Hims Class A Common Stock in exchange for Class A Common Stock of Hims, Inc.

F10 · ownership.nature: Mr. Maltz is a managing director of Institutional Venture Management XV LLC, which is the general partner of Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV Executive Fund") and Institutional Venture Partners XV, L.P. ("IVP XV"), and Institutional Venture Management XVI LLC, which is the general partner of Institutional Venture Partners XVI, L.P. ("IVP XVI"). Mr. Maltz may be deemed a beneficial owner of the securities held by IVP XV Executive Fund, IVP XV and IVP XVI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.

SEC source: 0000899243-21-003103 · doc4.xml · nonDerivative · entry 3

Maltz Jules A. · CIK 0001553254 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Institutional Venture Partners XVI, L.P.

Disclosed balance after: 10,186,538

F4 · price: In connection with the Merger, the Reporting Person received (i) 9,278,875 shares of Class A Common Stock of New Hims and (ii) 907,663 Earn Out Shares in exchange for 20,484,068 shares of Class A Common Stock of Hims, Inc. If the Earn Out Conditions are not met during the Earn Out Period, then the applicable Earn Out Shares will be automatically forfeited.

F10 · ownership.nature: Mr. Maltz is a managing director of Institutional Venture Management XV LLC, which is the general partner of Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV Executive Fund") and Institutional Venture Partners XV, L.P. ("IVP XV"), and Institutional Venture Management XVI LLC, which is the general partner of Institutional Venture Partners XVI, L.P. ("IVP XVI"). Mr. Maltz may be deemed a beneficial owner of the securities held by IVP XV Executive Fund, IVP XV and IVP XVI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.

SEC source: 0000899243-21-003103 · doc4.xml · nonDerivative · entry 2

Maltz Jules A. · CIK 0001553254 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Institutional Venture Partners XV, L.P.

Disclosed balance after: 10,132,631

F3 · price: In connection with the Merger, the Reporting Person received (i) 9,229,772 shares of Class A Common Stock of New Hims and (ii) 902,859 Earn Out Shares in exchange for 20,375,670 shares of Class A Common Stock of Hims, Inc. If the Earn Out Conditions are not met during the Earn Out Period, then the applicable Earn Out Shares will be automatically forfeited.

F10 · ownership.nature: Mr. Maltz is a managing director of Institutional Venture Management XV LLC, which is the general partner of Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV Executive Fund") and Institutional Venture Partners XV, L.P. ("IVP XV"), and Institutional Venture Management XVI LLC, which is the general partner of Institutional Venture Partners XVI, L.P. ("IVP XVI"). Mr. Maltz may be deemed a beneficial owner of the securities held by IVP XV Executive Fund, IVP XV and IVP XVI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.

SEC source: 0000899243-21-003103 · doc4.xml · nonDerivative · entry 1

Maltz Jules A. · CIK 0001553254 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Institutional Venture Partners XV Executive Fund, L.P.

Disclosed balance after: 53,895

F1 · price: In connection with the merger described in that certain Agreement and Plan of Merger, dated as of September 30, 2020 (the "Merger"), by and among Oaktree Acquisition Corp., now known as Hims & Hers Health, Inc. ("New Hims"), RX Merger Sub Inc., and Hims, Inc., the Reporting Person received (i) 49,097 shares of Class A Common Stock of New Hims and (ii) 4,798 shares of restricted New Hims Class A Common Stock (the "Earn Out Shares") in exchange for 108,397 Class A Common Stock of Hims, Inc. The Earn Out Shares vest in equal thirds if the trading price of New Hims Class A Common Stock is greater than or equal to $15, $17.50 and $20 for any 10 trading days within any 20-trading day period (the "Earn Out Conditions"). If the Earn Out Conditions are not met during the five years following closing (the "Earn Out Period"), then the unvested Earn Out Shares will be automatically forfeited.

F2 · price: (Continued from footnote 1) On the effective date of the Merger, the closing price of New Hims Class A Common Stock was $16.38 per share.

F10 · ownership.nature: Mr. Maltz is a managing director of Institutional Venture Management XV LLC, which is the general partner of Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV Executive Fund") and Institutional Venture Partners XV, L.P. ("IVP XV"), and Institutional Venture Management XVI LLC, which is the general partner of Institutional Venture Partners XVI, L.P. ("IVP XVI"). Mr. Maltz may be deemed a beneficial owner of the securities held by IVP XV Executive Fund, IVP XV and IVP XVI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.

SEC source: 0000899243-21-003102 · doc4.xml · derivative · entry 6

Green Kristen · CIK 0001770152 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,485

Underlying: Class A Common Stock · 3,485 shares

Expires not disclosed

F7 · derivative.exercise_price: In connection with the Merger, the Reporting Person received additional New Hims RSUs representing a portion of the aggregate 16,000,000 shares of New Hims Class A Common Stock comprising the Earn Out shares (the "Earn Out RSUs").

F8 · derivative.exercise_date: The Earn Out RSUs were received in exchange for shares of Legacy Hims RSUs. Subject to the satisfaction of time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition specified in Footnote 6 above. Additionally, the Earn Out RSUs will vest upon the satisfaction of the Earn Out conditions. If the RSU Earn Out conditions are not met during the Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited.

F8 · derivative.expiration_date: The Earn Out RSUs were received in exchange for shares of Legacy Hims RSUs. Subject to the satisfaction of time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition specified in Footnote 6 above. Additionally, the Earn Out RSUs will vest upon the satisfaction of the Earn Out conditions. If the RSU Earn Out conditions are not met during the Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited.

SEC source: 0000899243-21-003102 · doc4.xml · derivative · entry 5

Green Kristen · CIK 0001770152 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,627

Underlying: Class A Common Stock · 35,627 shares

Expires not disclosed

F5 · derivative.exercise_price: In connection with the Merger, the Reporting Person received New Hims restricted stock units ("New Hims RSUs") in exchange for restricted stock units of Hims, Inc. ("Legacy Hims RSUs").

F6 · derivative.exercise_date: The New Hims RSUs were received in exchange for 78,651 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period beginning in March 2021, with 25% of the New Hims RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of the vesting commencement date and the remaining 75% of the New Hims RSUs vesting in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter, subject to the individual's continuous service with the New Hims. The New Hims RSU expires in January 2028.

F6 · derivative.expiration_date: The New Hims RSUs were received in exchange for 78,651 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period beginning in March 2021, with 25% of the New Hims RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of the vesting commencement date and the remaining 75% of the New Hims RSUs vesting in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter, subject to the individual's continuous service with the New Hims. The New Hims RSU expires in January 2028.

SEC source: 0000899243-21-003102 · doc4.xml · derivative · entry 4

Green Kristen · CIK 0001770152 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Forerunner Partners III, L.P.

Disclosed balance after: 49,850

Underlying: Class A Common Stock · 49,850 shares

Expires 2026-01-20

F4 · derivative.exercise_date: In connection with the Merger, the Reporting Person received warrants exercisable for shares of New Hims Class A Common Stock in exchange for Class A Common Stock of Hims, Inc.

F9 · ownership.nature: Ms. Green is a managing member of Forerunner Ventures GP III, LLC, which is the general partner of Forerunner Builders II, L.P. and Forerunner Partners III, L.P. Ms. Green may be deemed a beneficial owner of the securities held by Forerunner Builders II, L.P. and Forerunner Partners III, L.P., but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.

SEC source: 0000899243-21-003102 · doc4.xml · derivative · entry 3

Green Kristen · CIK 0001770152 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Forerunner Builders II, L.P.

Disclosed balance after: 4,628

Underlying: Class A Common Stock · 4,628 shares

Expires 2026-01-20

F4 · derivative.exercise_date: In connection with the Merger, the Reporting Person received warrants exercisable for shares of New Hims Class A Common Stock in exchange for Class A Common Stock of Hims, Inc.

F9 · ownership.nature: Ms. Green is a managing member of Forerunner Ventures GP III, LLC, which is the general partner of Forerunner Builders II, L.P. and Forerunner Partners III, L.P. Ms. Green may be deemed a beneficial owner of the securities held by Forerunner Builders II, L.P. and Forerunner Partners III, L.P., but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.

SEC source: 0000899243-21-003102 · doc4.xml · nonDerivative · entry 2

Green Kristen · CIK 0001770152 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Forerunner Partners III, L.P.

Disclosed balance after: 8,914,715

F3 · price: In connection with the Merger, the Reporting Person received (i) 8,120,380 shares of Class A Common Stock of New Hims and (ii) 794,335 Earn Out Shares in exchange for 17,926,574 shares of Class A Common Stock of Hims, Inc. If the Earn Out Conditions are not met during the Earnout Period, then the applicable Earn Out Shares will be automatically forfeited.

F9 · ownership.nature: Ms. Green is a managing member of Forerunner Ventures GP III, LLC, which is the general partner of Forerunner Builders II, L.P. and Forerunner Partners III, L.P. Ms. Green may be deemed a beneficial owner of the securities held by Forerunner Builders II, L.P. and Forerunner Partners III, L.P., but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.

SEC source: 0000899243-21-003102 · doc4.xml · nonDerivative · entry 1

Green Kristen · CIK 0001770152 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Forerunner Builders II, L.P.

Disclosed balance after: 827,634

F1 · price: In connection with the merger described in that certain Agreement and Plan of Merger, dated as of September 30, 2020 (the "Merger"), by and among Oaktree Acquisition Corp., now known as Hims & Hers Health, Inc. ("New Hims"), RX Merger Sub Inc., and Hims, Inc., the Reporting Person received (i) 753,889 shares of Class A Common Stock of New Hims and (ii) 73,745 shares of restricted New Hims Class A Common Stock (the "Earn Out Shares") in exchange for 1,664,289 Class A Common Stock of Hims, Inc. The Earn Out Shares vest in equal thirds if the trading price of New Hims Class A Common Stock is greater than or equal to $15, $17.50 and $20 for any 10 trading days within any 20-trading day period (the "Earn Out Conditions"). If the Earn Out Conditions are not met during the five years following closing (the "Earn Out Period"), then the unvested Earn Out Shares will be automatically forfeited.

F2 · price: (Continued from footnote 1) On the effective date of the Merger, the closing price of New Hims Class A Common Stock was $16.38 per share.

F9 · ownership.nature: Ms. Green is a managing member of Forerunner Ventures GP III, LLC, which is the general partner of Forerunner Builders II, L.P. and Forerunner Partners III, L.P. Ms. Green may be deemed a beneficial owner of the securities held by Forerunner Builders II, L.P. and Forerunner Partners III, L.P., but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.

SEC source: 0000899243-21-003101 · doc4.xml · derivative · entry 1

Cosgrove Delos M. · CIK 0001824222 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,596

Underlying: Class A Common Stock · 90,596 shares

Expires 2029-11-05

F1 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 200,000 shares of Class A Common Stock of Hims, Inc, with an exercise price of $0.79, in connection with the merger described in that certain Agreement and Plan of Merger, dated as of September 30, 2020, by and among Oaktree Acquisition Corp., now known as Hims & Hers Health, Inc. The Stock Option vests with respect to 1/48th of the shares subject to the Stock Option when the Reporting Person completes each month of continuous service beginning November 6, 2019.

SEC source: 0000899243-21-003094 · doc4.xml · derivative · entry 13

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held By Atomic Labs II, L.P.

Disclosed balance after: 46,238

Underlying: Class A Common Stock · 46,238 shares

Expires 2026-01-20

F14 · derivative.exercise_date: In connection with the Merger, the Reporting Person received additional New Hims warrants in exchange for Class A Common Stock of Hims, Inc.

F15 · ownership.nature: Mr. Dudum is a managing member of Atomic GP II, LLC, the general partner and manager of Atomic Labs II, L.P. Mr. Dudum may be deemed the beneficial owner of the shares held by Atomic Labs II, L.P., but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.

SEC source: 0000899243-21-003094 · doc4.xml · derivative · entry 12

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Trustee of the AD GRAT dated 8/31/20

Disclosed balance after: 16,028

Underlying: Class A Common Stock · 16,028 shares

Expires 2026-01-20

F14 · derivative.exercise_date: In connection with the Merger, the Reporting Person received additional New Hims warrants in exchange for Class A Common Stock of Hims, Inc.

SEC source: 0000899243-21-003094 · doc4.xml · derivative · entry 11

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015

Disclosed balance after: 94,582

Underlying: Class A Common Stock · 94,582 shares

Expires 2026-01-20

F14 · derivative.exercise_date: In connection with the Merger, the Reporting Person received additional New Hims warrants in exchange for Class A Common Stock of Hims, Inc.

SEC source: 0000899243-21-003094 · doc4.xml · derivative · entry 10

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,624

Underlying: Class A Common Stock · 28,624 shares

Expires not disclosed

F12 · derivative.exercise_price: In connection with the Merger, the Reporting Person received additional New Hims RSUs representing a portion of the aggregate 16,000,000 shares of New Hims Class A Common Stock comprising the Earn Out Shares (the "Earn Out RSUs").

F13 · derivative.exercise_date: The Earn Out RSUs were received in exchange for Legacy Hims RSUs. Subject to the satisfaction of a time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition specified in Footnote 11 above. Additionally, the Earn Out RSUs will vest upon the satisfaction of the Earn Out Conditions. If the RSU Earn Out Conditions are not met during the Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited.

F13 · derivative.expiration_date: The Earn Out RSUs were received in exchange for Legacy Hims RSUs. Subject to the satisfaction of a time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition specified in Footnote 11 above. Additionally, the Earn Out RSUs will vest upon the satisfaction of the Earn Out Conditions. If the RSU Earn Out Conditions are not met during the Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited.

SEC source: 0000899243-21-003094 · doc4.xml · derivative · entry 9

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,625

Underlying: Class A Common Stock · 292,625 shares

Expires not disclosed

F10 · derivative.exercise_price: In connection with the Merger, the Reporting Person received New Hims restricted stock units ("New Hims RSUs") in exchange for restricted stock units of Hims, Inc. ("Legacy Hims RSUs").

F11 · derivative.exercise_date: The New Hims RSUs were received in exchange for 646,000 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period in substantially equal quarterly installments beginning March 15, 2021, with 6.25% of the RSUs vesting on each of March 15, June 15, September 15 and December 15, subject to the individual's continuous service. The New Hims RSU is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable RSU Agreement). The New Hims RSU expires in December 2027.

F11 · derivative.expiration_date: The New Hims RSUs were received in exchange for 646,000 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period in substantially equal quarterly installments beginning March 15, 2021, with 6.25% of the RSUs vesting on each of March 15, June 15, September 15 and December 15, subject to the individual's continuous service. The New Hims RSU is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable RSU Agreement). The New Hims RSU expires in December 2027.

SEC source: 0000899243-21-003094 · doc4.xml · derivative · entry 8

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 584,797

Underlying: Class A Common Stock · 584,797 shares

Expires 2020-12-23

F9 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 1,291,000 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous service beginning with December 16, 2020.

SEC source: 0000899243-21-003094 · doc4.xml · derivative · entry 7

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,623,069

Underlying: Class A Common Stock · 1,623,069 shares

Expires 2030-06-16

F8 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 100% of the shares subject to the option vest when (i) New Hims is acquired and the per share consideration is equal to at least the Threshold Amount or (ii) the per share closing trading price of New Hims' Class A Common Stock on a public stock exchange is at least equal to the Threshold Amount, provided that the Reporting Person remains in continuous service as CEO or a director of New Hims through the acquisition or Achievement Date, as applicable.

SEC source: 0000899243-21-003094 · doc4.xml · derivative · entry 6

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,246,139

Underlying: Class A Common Stock · 3,246,139 shares

Expires 2030-06-16

F7 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 7,166,182 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 100% of the shares subject to the Stock Option vest when (i) New Hims is acquired and the per share consideration is equal to at least $17.35 per share (subject to appropriate adjustment for the Merger, stock splits and otherwise, the "Threshold Amount") or (ii) the per share closing trading price of New Hims' Class A Common Stock on a public stock exchange is at least equal to the Threshold Amount (the date on which such closing trading price is achieved, the "Achievement Date"), provided that the Reporting Person remains in continuous service as CEO or a director through the acquisition or Achievement Date, as applicable.

SEC source: 0000899243-21-003094 · doc4.xml · derivative · entry 5

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,623,069

Underlying: Class A Common Stock · 1,623,069 shares

Expires 2030-06-16

F6 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.

SEC source: 0000899243-21-003094 · doc4.xml · derivative · entry 4

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Andrew Dudum 2015 Trust Dated July 2, 2015

Disclosed balance after: 8,377,623

Underlying: Class A Common Stock · 8,377,623 shares

Expires not disclosed

F5 · derivative.exercise_price: In connection with the Merger, the Reporting Person received shares of New Hims Class V Common Stock in exchange for shares of Class V Common Stock of Hims, Inc. As specified in that New Hims Certificate of Incorporation, dated as of January 20, 2021 (the "Charter"), New Hims Class V Common Stock is convertible into an equal number of fully paid and nonassessable shares of New Hims Class A Common Stock upon certain events.

F5 · derivative.exercise_date: In connection with the Merger, the Reporting Person received shares of New Hims Class V Common Stock in exchange for shares of Class V Common Stock of Hims, Inc. As specified in that New Hims Certificate of Incorporation, dated as of January 20, 2021 (the "Charter"), New Hims Class V Common Stock is convertible into an equal number of fully paid and nonassessable shares of New Hims Class A Common Stock upon certain events.

F5 · derivative.expiration_date: In connection with the Merger, the Reporting Person received shares of New Hims Class V Common Stock in exchange for shares of Class V Common Stock of Hims, Inc. As specified in that New Hims Certificate of Incorporation, dated as of January 20, 2021 (the "Charter"), New Hims Class V Common Stock is convertible into an equal number of fully paid and nonassessable shares of New Hims Class A Common Stock upon certain events.

SEC source: 0000899243-21-003094 · doc4.xml · nonDerivative · entry 3

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Atomic Labs II, L.P.

Disclosed balance after: 8,268,565

F4 · price: In connection with the Merger, the Reporting Person received (i) 7,531,800 shares of Class A Common Stock of New Hims and (ii) 736,765 Earn Out Shares in exchange for 16,627,218 shares of Class A Common Stock of Hims, Inc. If the Earn Out Conditions are not met during the Earn Out Period, then the applicable Earn Out Shares will be automatically forfeited.

F15 · ownership.nature: Mr. Dudum is a managing member of Atomic GP II, LLC, the general partner and manager of Atomic Labs II, L.P. Mr. Dudum may be deemed the beneficial owner of the shares held by Atomic Labs II, L.P., but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.

SEC source: 0000899243-21-003094 · doc4.xml · nonDerivative · entry 2

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by AD GRAT dated 8/31/20

Disclosed balance after: 2,866,230

F3 · price: In connection with the Merger, the Reporting Person received (i) 2,610,837 shares of Class A Common Stock of New Hims and (ii) 255,393 Earn Out Shares in exchange for 5,763,689 shares of Class A Common Stock of Hims, Inc. If the Earn Out Conditions are not met during the Earn Out Period, then the unvested Earn Out Shares will be automatically forfeited.

SEC source: 0000899243-21-003094 · doc4.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Andrew Dudum 2015 Trust Dated July 2, 2015

Disclosed balance after: 8,207,151

F1 · price: In connection with the merger described in that certain Agreement and Plan of Merger, dated as of September 30, 2020 (the "Merger"), by and among Oaktree Acquisition Corp., now known as Hims & Hers Health, Inc. ("New Hims"), RX Merger Sub Inc., and Hims, Inc., the Reporting Person received (i) 6,700,108 shares of Class A Common Stock of New Hims and (ii) 1,507,043 shares of restricted New Hims Class A Common Stock (the "Earn Out Shares") in exchange for 15,516,292 shares of Class A Common Stock of Hims, Inc. The Earn Out Shares vest in equal thirds if the trading price of New Hims Class A Common Stock is greater than or equal to $15, $17.50 and $20 for any 10 trading days within any 20-trading day period (the "Earn Out Conditions"). If the Earn Out Conditions are not met during the five years following closing (the "Earn Out Period"), then the unvested Earn Out Shares will be automatically forfeited.

F2 · price: (Continued form footnote 1) On the effective date of the Merger, the closing price of New Hims Class A Common Stock was $16.38 per share.

SEC source: 0000899243-21-003097 · doc4.xml · derivative · entry 4

O'Keefe Lynne Chou · CIK 0001837800 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,295

Underlying: Class A Common Stock · 14,295 shares

Expires not disclosed

F6 · derivative.exercise_price: In connection with the Merger, the Reporting Person received additional New Hims RSUs representing a portion of the aggregate 16,000,000 shares of New Hims Class A Common Stock comprising the Earn Out shares (the "Earn Out RSUs").

F7 · derivative.exercise_date: The Earn Out RSUs were received in exchange for Legacy Hims RSUs. Subject to the satisfaction of a time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition as specified in Footnote 5 above. Additionally, the Earn Out RSUs will vest upon the satisfaction of the Earn Out conditions. If the RSU Earnout Conditions are not met during the RSU Earnout Period, then the applicable Earnout RSUs will be automatically forfeited.

F7 · derivative.expiration_date: The Earn Out RSUs were received in exchange for Legacy Hims RSUs. Subject to the satisfaction of a time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition as specified in Footnote 5 above. Additionally, the Earn Out RSUs will vest upon the satisfaction of the Earn Out conditions. If the RSU Earnout Conditions are not met during the RSU Earnout Period, then the applicable Earnout RSUs will be automatically forfeited.

SEC source: 0000899243-21-003097 · doc4.xml · derivative · entry 3

O'Keefe Lynne Chou · CIK 0001837800 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,137

Underlying: Class A Common Stock · 146,137 shares

Expires not disclosed

F4 · derivative.exercise_price: In connection with the Merger, the Reporting Person received New Hims restricted stock units ("New Hims RSUs") in exchange for restricted stock units of Hims, Inc. ("Legacy Hims RSUs").

F5 · derivative.exercise_date: The New Hims RSUs were received in exchange for 322,613 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period commencing in December 2020, with 25% of the New Hims RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of the vesting commencement date and the remaining 75% of the New Hims RSUs vesting in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter, subject to the individual's continuous service with New Hims.

F5 · derivative.expiration_date: The New Hims RSUs were received in exchange for 322,613 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period commencing in December 2020, with 25% of the New Hims RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of the vesting commencement date and the remaining 75% of the New Hims RSUs vesting in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter, subject to the individual's continuous service with New Hims.